Home OriCiro

OriCiro

In operation
Series B
Innovative Therapy Developer
Basic
Enterprise Profile

Basic Information

OriCiro Genomics is a Japanese biotech innovator specializing in cell-free synthesis and amplification of genomes for advanced therapies and synthetic biology. OriCiro's proprietary technology aims to unlock the potential of advanced therapies and synthetic biology by providing robust tools for research, development, and manufacturing across multiple industries, including pharmaceuticals, diagnostics, agriculture, and food. The company is based in Tokyo, Japan.
OriCiro Genomics, Inc.
Tokyo,Tokyo,Japan
unclear
December 01, 2018
contact@oriciro.com

Enterprise Profile

Industrial Sector
New Drug Development CRO
Technology
Gene Technology Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs